DNA - Focused Set
DMET
Expression Analysis provides comprehensive analysis of patient genotypes for predicting drug response and metabolic profiling. DMET is the only product available that covers over 90% of ADME Core drug metabolism biomarkers defined by the PharmaADME group (1936 known drug metabolism markers in 225 genes), including common and rare variations, insertions, deletions, copy number, triallelic SNPs and pseudogenes. DMET arrays are useful for discovering new biomarkers, determining drug responders, identifying populations or drug response outliers, selective patient recruitment, differentiating new drugs, optimizing reactivity and for mechanism of action (MOA) studies.